Brunswick (BC) director McClanathan reports purchase of 934 common shares

Rhea-AI Filing Summary

Brunswick Corporation director Joseph W. McClanathan reported an acquisition of company stock. On 01/30/2026, he acquired 934 shares of Brunswick common stock at $80.22 per share. After this transaction, he beneficially owned 26,898 shares held directly.

Footnotes explain that 412 of these shares are deferred into a director deferred account, to be distributed in installments after he leaves the board. His beneficial holdings also include 122 shares received through dividend reinvestment in December 2025.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MCCLANATHAN JOSEPH W

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	934	$80.22	$75K

Holdings After Transaction: Common Stock — 26,898 shares (Direct)

Footnotes (1)

1. 412 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 122 shares acquired pursuant to dividend reinvestment in December 2025.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCCLANATHAN JOSEPH W

(Last) (First) (Middle)

C/O BRUNSWICK CORPORATION

26125 N RIVERWOODS BLVD SUITE 500

(Street)

METTAWA IL 60045-3420

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUNSWICK CORP [ BC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/30/2026		A		934(1)	A	$80.22	26,898(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 412 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.

2. Beneficial holdings include 122 shares acquired pursuant to dividend reinvestment in December 2025.

Remarks:

	By: Power of Attorney For: /s/ Joseph W. McClanathan	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Brunswick (BC) report for Joseph W. McClanathan?

Brunswick reported that director Joseph W. McClanathan acquired 934 common shares. The shares were acquired on 01/30/2026 at $80.22 per share, increasing his directly held beneficial ownership to 26,898 Brunswick shares according to the Form 4 filing.

At what price did the Brunswick (BC) director acquire the 934 shares?

The 934 Brunswick common shares were acquired at $80.22 per share. This per-share price is disclosed in the Form 4 transaction table, which records the award-coded transaction and the updated total number of shares beneficially owned afterward.

How many Brunswick (BC) shares does Joseph W. McClanathan own after this transaction?

After the transaction, McClanathan beneficially owned 26,898 Brunswick shares. This total, reported as directly held, reflects the new 934-share acquisition, deferred shares in his director account, and shares accumulated through dividend reinvestment as described in the footnotes.

What are the deferred shares mentioned in the Brunswick (BC) Form 4 footnote?

The filing states that 412 of the reported shares are deferred shares. These are deposited in McClanathan’s director deferred account and will be automatically distributed in predetermined installments after he ceases serving as a Brunswick director, according to the disclosure.

How were dividend reinvestment shares disclosed for Brunswick (BC) in this Form 4?

The Form 4 notes that beneficial holdings include 122 dividend reinvestment shares. A footnote explains these shares were acquired through dividend reinvestment in December 2025, and they form part of McClanathan’s total beneficial ownership in Brunswick.

What role does Joseph W. McClanathan hold at Brunswick (BC) in this filing?

The Form 4 identifies Joseph W. McClanathan as a director of Brunswick. The relationship section is marked to show he is a director, with no officer title or 10% ownership status indicated in the structured reporting person information.